1. Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients 
M. Todd Greene, PhD, MPH, Alex C. Spyropoulos, MD, Vineet Chopra, MD, MSc, Paul J. Grant, MD, Scott Kaatz, DO, MSc, Steven J. Bernstein, MD, MPH, Scott A. Flanders, MD 
The American Journal of Medicine 
Volume 129, Issue 9, Pages 1001.e e18 (September 2016)
DOI: /j.amjmed
Copyright © Terms and Conditions

2. Figure
Risk assessment model description. BMI = body mass index; CHF = congestive heart failure; MI = myocardial infarction; PICC = peripherally inserted central catheter; RAM = risk assessment model; VTE = venous thromboembolism. aHistory of thrombophilia includes positive Factor V Leiden, positive prothrombin, G20210A gene mutation, positive lupus anticoagulant, other congenial or acquired thrombophilia. bCurrent cancer defined as cancer diagnosed or treated within the year prior to hospital admission. cImmobile defined as having at least one of the following: immobilizing plaster cast, paralysis, or bed rest for ≥72 hours prior to hospitalization. dOther acute infections include primary reason for admission based on the following Healthcare Cost and Utilization Project (HCUP) infection categories: Tuberculosis, Septicemia, 1.3 - Bacterial infection, unspecified site, Mycoses, HIV infection, Hepatitis, 1.7 - Viral infections, Other infections, including parasitic, Sexually transmitted infection (not HIV or hepatitis), Other CNS infection and poliomyelitis, Inflammation, infection of the eye, Other upper respiratory infection, Intestinal infection,  Urinary tract infections, Skin and subcutaneous tissue infection, and Infective arthritis and osteomyelitis. ePICC presence defined as admitted with PICC or inserted on day 1 or 2 of hospitalization.
The American Journal of Medicine  , 1001.e e18DOI: ( /j.amjmed )
Copyright © Terms and Conditions